Challenges & Promises of Personalized Cancer Vaccines: Learnings From Autogene Cevumeran
Time: 9:00 am
day: Conference Day Two
Details:
- Preclinical studies: vaccine immunogenicity and anti-tumor response
- Showcasing phase 1 clinical data
- Determining the vaccine mechanism of action
